$2.72
+0.0300 (+1.12%)
At Close: Jun 03, 2026
Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the signing of a strategic collaboration and license agreement with Takeda Pharmaceutical Company
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene ...
12:00am, Monday, 23'rd Mar 2020Is Codexis, Inc. (NASDAQ:CDXS) Trading At A 31% Discount?
10:43am, Monday, 16'th Mar 2020
Does the March share price for Codexis, Inc. (NASDAQ:CDXS) reflect what it's really worth? Today, we will estimate the...
Codexis, Inc. (NASDAQ:CDXS) Shares Acquired by Charles Schwab Investment Management Inc.
09:54am, Saturday, 14'th Mar 2020
Charles Schwab Investment Management Inc. increased its stake in shares of Codexis, Inc. (NASDAQ:CDXS) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with th
Edited Transcript of CDXS earnings conference call or presentation 27-Feb-20 9:30pm GMT
05:57pm, Friday, 13'th Mar 2020
Q4 2019 Codexis Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Codexis (NASDAQ:CDXS) Stock Rating Upgraded by BidaskClub
09:08am, Thursday, 12'th Mar 2020
Codexis (NASDAQ:CDXS) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Tuesday, BidAskClub
Stocks That Hit 52-Week Lows On Wednesday
03:41pm, Wednesday, 11'th Mar 2020
During Wednesday's morning session, 690 stocks hit new 52-week lows.
Intriguing Points:
Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...
Jefferies likes United Therapeutics in premarket analyst action
11:56am, Tuesday, 10'th Mar 2020
Appili Therapeutics (APLI CN) initiated with Buy rating and C$4 (602% upside) price target at Maxim Group.Aphria (NYSE:APHA) initiated with Hold rating and C$4.50 (7% upside) price target at Stifel. S
Barclays PLC Increases Stake in Codexis, Inc. (NASDAQ:CDXS)
08:54am, Monday, 09'th Mar 2020
Barclays PLC lifted its stake in shares of Codexis, Inc. (NASDAQ:CDXS) by 272.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commiss
Fmr LLC Reduces Position in Codexis, Inc. (NASDAQ:CDXS)
08:38am, Sunday, 08'th Mar 2020
Fmr LLC trimmed its position in Codexis, Inc. (NASDAQ:CDXS) by 12.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The f
ValuEngine Downgrades Codexis (NASDAQ:CDXS) to Buy
08:08am, Wednesday, 04'th Mar 2020
Codexis (NASDAQ:CDXS) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday, ValuEngine reports. A number of o
Analysts Expect Codexis, Inc. (NASDAQ:CDXS) to Post -$0.03 EPS
10:18am, Tuesday, 03'rd Mar 2020
Analysts expect Codexis, Inc. (NASDAQ:CDXS) to report ($0.03) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Codexi
Sign In
Buy CDXS